SEC Form 4 · accession 0001209191-18-048435
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Toshinari Tamura
Director
Period of report
Aug 22, 2018
Accepted (ET)
Aug 24, 2018 · 7:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 22, 2018 | M | 12,000 | $19.05 | A | 63,700 | D | |
| Common Stock | Aug 22, 2018 | S | 12,000 | $60.65 | D | 51,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.05 | Aug 22, 2018 | M | 12,000 | D | — | Jun 8, 2026 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1Fully vested.